Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.44 |
| ▸ | LPL | P06858 | 3/20 | 0.44 |
| ▸ | HTR2B | P41595 | 2/20 | 0.32 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20094953 | 0.97 | LIPG (0.41) | LIPGLPLHTR2BTMEM97SIGMAR1 | |
| SCHEMBL19928042 | 0.87 | L3MBTL1 (0.37) | LIPGLPLMAPK1SMN1; SMN2HSD17B10 | |
| SCHEMBL28521876 | 0.85 | LIPG (0.61) | LIPGLPLHTR2BTMEM97SIGMAR1 | |
| SCHEMBL18467899 | 0.85 | LPL (0.44) | LIPGLPL | |
| SCHEMBL19905011 | 0.85 | LPL (0.44) | LIPGLPL | |
| SCHEMBL18773569 | 0.84 | DGAT1 (0.47) | HTR2BTMEM97SIGMAR1 | |
| SCHEMBL30257732 | 0.84 | LPL (0.33) | LIPGLPL | |
| SCHEMBL28545424 | 0.81 | CHRNA1 (0.35) | LIPGLPLMAPK1 | |
| SCHEMBL18597867 | 0.79 | HPGD (0.35) | LIPGLPL | |
| SCHEMBL3362199 | 0.78 | LIPG (0.70) | LIPGLPLMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210013426-A1 | COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210013426-A1 | COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | OR10J3, OXER1, OR51E2 | LIPG 1211/4885LPL 3584/4885HTR2B 2248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.